Treatment for cancer pain in France

BMJ 1995; 311 doi: https://doi.org/10.1136/bmj.311.7001.387 (Published 05 August 1995) Cite this as: BMJ 1995;311:387
  1. M Zenz, Professor,
  2. T Zenz
  1. Medical student Department of Anaesthesiology, Intensive Pain, and Pain Therapy, University Hospital Bergmannsheil, Burk-de-la-Campe Platz 1, D 44789 Bochum, Germany

    EDITOR,--Francois Larue and colleagues draw attention to the persisting problem of undertreatment of cancer pain.1 In their French multicentre study of patients (most of whom were inpatients) 30% (84/279) of patients with cancer pain received no analgesic drugs. Of those patients given analgesics, 51% (137/270) received inadequate treatment for their pain. Discrepancy between physicians' and patients' pain ratings, young age of the patient, absence of metastatic disease, and better performance status were predictors for the undertreatment of cancer pain. The authors conclude that …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription